Literature DB >> 10967148

Incidence and preventability of adverse drug events in nursing homes.

J H Gurwitz1, T S Field, J Avorn, D McCormick, S Jain, M Eckler, M Benser, A C Edmondson, D W Bates.   

Abstract

PURPOSE: Adverse drug events, especially those that may have been preventable, are among the most serious concerns about medication use in nursing homes. We studied the incidence and preventability of adverse drug events and potential adverse drug events in nursing homes.
METHODS: We performed a cohort study of all long-term care residents of 18 community-based nursing homes in Massachusetts during a 12-month observation period. Potential drug-related incidents were detected by stimulated self-report by nursing home staff and by periodic review of the records of nursing home residents by trained nurse and pharmacist investigators. Each incident was classified by 2 independent physician-reviewers, using a structured implicit review process, by whether or not it constituted an adverse drug event or potential adverse drug event (those that may have caused harm, but did not because of chance or because they were detected), by the severity of the event (significant, serious, life-threatening, or fatal), and by whether it was preventable. Examples of significant events included nonurticarial rashes, falls without associated fracture, hemorrhage not requiring transfusion or hospitalization, and oversedation; examples of serious events included urticaria, falls with fracture, hemorrhage requiring transfusion or hospitalization, and delirium.
RESULTS: During 28,839 nursing home resident-months of observation in the 18 participating nursing homes, 546 adverse drug events (1.89 per 100 resident-months) and 188 potential adverse drug events (0.65 per 100 resident-months) were identified. Of the adverse drug events, 1 was fatal, 31 (6%) were life-threatening, 206 (38%) were serious, and 308 (56%) were significant. Overall, 51% of the adverse drug events were judged to be preventable, including 171 (72%) of the 238 fatal, life-threatening, or serious events and 105 (34%) of the 308 significant events (P < 0.001). Errors resulting in preventable adverse drug events occurred most often at the stages of ordering and monitoring; errors in transcription, dispensing, and administration were less commonly identified. Psychoactive medications (antipsychotics, antidepressants, and sedatives/hypnotics) and anticoagulants were the most common medications associated with preventable adverse drug events. Neuropsychiatric events were the most common types of preventable adverse drug events.
CONCLUSIONS: Adverse drug events are common and often preventable in nursing homes. More serious adverse drug events are more likely to be preventable. Prevention strategies should target the ordering and monitoring stages of pharmaceutical care.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967148     DOI: 10.1016/s0002-9343(00)00451-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  138 in total

1.  Nursing and residential care for the elderly in Northern Ireland: the contribution of the pharmacist.

Authors:  A K Schweizer; C M Hughes
Journal:  Pharm World Sci       Date:  2001-10

2.  Clinician use of a palmtop drug reference guide.

Authors:  Jeffrey M Rothschild; Thomas H Lee; Taran Bae; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2002 May-Jun       Impact factor: 4.497

3.  Does national regulatory mandate of provider order entry portend greater benefit than risk for health care delivery? The 2001 ACMI debate. The American College of Medical Informatics.

Authors:  J Marc Overhage; Blackford Middleton; Randolph A Miller; Rita D Zielstorff; William R Hersh
Journal:  J Am Med Inform Assoc       Date:  2002 May-Jun       Impact factor: 4.497

4.  Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes.

Authors:  E Eide; J Schjøtt; J Schjøt
Journal:  Pharm World Sci       Date:  2001-12

5.  Developing a taxonomy for research in adverse drug events: potholes and signposts.

Authors:  J R Nebeker; J F Hurdle; J Hoffman; B Roth; C R Weir; M H Samore
Journal:  Proc AMIA Symp       Date:  2001

6.  Health care for older people.

Authors:  Paula A Rochon; Susan E Bronskill; Jerry H Gurwitz
Journal:  BMJ       Date:  2002-05-25

7.  Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study.

Authors:  S Ruths; J Straand; H A Nygaard
Journal:  Qual Saf Health Care       Date:  2003-06

Review 8.  The key role of clinical and community health nurses in pharmacovigilance.

Authors:  Caterina Bigi; Guido Bocci
Journal:  Eur J Clin Pharmacol       Date:  2017-08-02       Impact factor: 2.953

9.  MedIntegrate: Incorporating provincially funded community pharmacist services into an ambulatory internal medicine clinic to enhance medication reconciliation.

Authors:  Marko Tomas; Natalie Crown; Debaroti Borschel; Lisa McCarthy
Journal:  Can Pharm J (Ott)       Date:  2014-09

10.  Provider management of and satisfaction with laboratory testing in the nursing home setting: results of a national internet-based survey.

Authors:  Brian H Shirts; Subashan Perera; Joseph T Hanlon; Yazan F Roumani; Stephanie A Studenski; David A Nace; Michael J Becich; Steven M Handler
Journal:  J Am Med Dir Assoc       Date:  2009-01-08       Impact factor: 4.669

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.